Can targeted biologics help manage my prurigo nodularis?

Question

Hello doctor,

I have had prurigo nodularis for over three years now, and it has been very hard to sleep or function with all this itching and skin lesions. Steroids and antihistamines did not help much. I read somewhere that IL-31-targeted biologics are safe for long-term use. I have a few concerns:

Do they help in reducing the number of nodules or just itch?
Is prurigo linked with any autoimmune stuff I should check for?
Could it be worsened by my anxiety and thyroid issues, too?

Kindly help.

Answer 1

Hello,

Welcome to icliniq.com.

I read your query and understand your concern.

Prurigo nodularis can indeed be very challenging due to the intense itching and skin lesions, which significantly affect sleep and daily functioning.

Regarding IL-31 targeted biologics, such as Nemolizumab, they are a newer class of treatments designed specifically to reduce itching by blocking the interleukin (IL-31) pathway involved in itch signaling. Clinical studies have shown that these medications can effectively reduce itch severity and improve quality of life. However, their impact on reducing the actual number or size of nodules is less clear; they primarily help control the itch rather than directly shrinking the lesions. Long-term safety data is still being collected, but so far, these treatments have been generally well tolerated under medical supervision.

Prurigo nodularis is not typically classified as an autoimmune disease, but it is often associated with chronic skin inflammation and can be linked to underlying conditions such as atopy, chronic kidney disease, or neurological disorders. It is wise to have a thorough evaluation to rule out any contributing systemic issues.

Your anxiety and thyroid problems can indeed influence your prurigo symptoms. Stress and anxiety may worsen itching and skin inflammation, and thyroid dysfunction can also affect skin health. Managing these conditions in parallel with your skin treatment can help improve overall symptoms.

I recommend discussing these options with your dermatologist or specialist, who can tailor a treatment plan suited to your specific case, including whether IL-31 targeted therapy might be appropriate for you.

I hope this helps.

Thank you.